Early Signs And Risk Factors For The Increased Incidence Of Epstein-Barr Virus-Related Posttransplant Lymphoproliferative Diseases In Pediatric Liver Transplant Recipients Treated With Tacrolimus-Reference-Cited by-同舟云学术

Early Signs And Risk Factors For The Increased Incidence Of Epstein-Barr Virus-Related Posttransplant Lymphoproliferative Diseases In Pediatric Liver Transplant Recipients Treated With Tacrolimus

Published:1997-11 Issue:10 Volume:64 Page:1438-1442
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Sokal Etienne Marc,Antunes Henedina,Beguin Claire,Bodeus Monique,Wallemacq Pierre,de Goyet Jean de Ville,Reding Raymond,Janssen Magda,Buts Jean Paul,Otte Jean Bernard

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference12 articles.

1. EPSTEIN-BARR VIRUS SEROLOGY AND EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS

2. AN INCREASED INCIDENCE OF EPSTEIN-BARR VIRUS INFECTION AND LYMPHOPROLIFERATIVE DISORDER IN YOUNG CHILDREN ON FK506 AFTER LIVER TRANSPLANTATION1

3. A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

4. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection

5. CONVERSION FROM CYCLOSPORINE TO FK506 FOR SALVAGE OF IMMUNOCOMPROMISED PEDIATRIC LIVER ALLOGRAFTS EFFICACY, TOXICITY, AND DOSE REGIMEN IN 23 CHILDREN

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis–Associated Lymphoproliferative Disorders;Arthritis & Rheumatology;2024-03-13

2. Viral agents (2nd section);Transfusion;2024-02

3. Prevalence of Human Adenovirus, Epstein-Barr Virus, and Cytomegalovirus in Pediatric Hematologic Diseases in Iran;Infection Epidemiology and Microbiology;2024-02-01

4. Immune dysregulation as a leading principle for lymphoma development in diverse immunological backgrounds;Immunology Letters;2023-11

5. Seropositivity for cytomegalovirus and PCR‐EBV monitoring: Protective factors for posttransplant lymphoproliferative disorder in pediatric liver transplant;Pediatric Transplantation;2022-01-17